Neurofibromatosis Treatment News and Information

What is Neurofibromatosis?

Neurofibromatosis (NF) is a genetic neurological disorder which can affect areas of the nervous system including the brain, spinal cord and nerves.The disorder causes tumors to form on nerve tissue. The tumors are usually noncancerous (benign), but sometimes can become cancerous (malignant). Complications resulting from neurofibromatosis can include hearing loss, learning impairment, heart and blood vessel (cardiovascular) problems, loss of vision, and severe pain.

See below for updated news and information regarding Neurofibromatosis including new medical research, treatment options and advancements. 

Latest Neurofibromatosis Treatment News and Research

Neurofibromatosis Research: Early-phase trial demonstrates shrinkage in pediatric neural tumors

(SOURCE: NATIONAL CANCER INSTITUTE) - In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage. NF1 affects 1 in 3,000 people. The study results appeared Dec. 29, 2016, in the ...
Read More